A California medical technology company and one of its former executives have agreed to resolve criminal ​charges that they ...

Background Intracerebral hemorrhage (ICH) is the stroke subtype with the highest mortality and disability rates, and early hematoma evacuation is crucial for improving prognosis. Compared to ...

Vitestro's ARPD blood-drawing robot gained an EU CE mark in 2024 and launched in the healthcare settings across the region in ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

Treatment-naïve BRVO eyes showed logMAR BCVA improvement (0.64 to 0.41) alongside CRT reduction (527 µm to 285 µm) over short-term follow-up with SB15. Central RVO eyes improved from logMAR 1.29 to 0.

Every year, thousands of people are blinded suddenly, like Durst, by injuries to their cornea, the dome-shaped lenses that cap each iris. These injuries are often debilitating. In the weeks after his ...

Current treatments for corneal neovascularization rely on invasive intravitreal injections, which limit patient compliance and carry significant risks. To address this, researchers developed a ...

FLACS combined with vitrectomy offers shorter surgical duration and better visual recovery than conventional phacoemulsification plus vitrectomy.

Scleral buckle repair for rhegmatogenous retinal detachment yields favorable visual outcomes in young adults, a study shows.